237 related articles for article (PubMed ID: 30154686)
1. The Role of
Deng S; Zhang B; Zhou Y; Xu X; Li J; Sang S; Zhang W
Contrast Media Mol Imaging; 2018; 2018():4198673. PubMed ID: 30154686
[TBL] [Abstract][Full Text] [Related]
2. Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe).
Nanni C; Versari A; Chauvie S; Bertone E; Bianchi A; Rensi M; Bellò M; Gallamini A; Patriarca F; Gay F; Gamberi B; Ghedini P; Cavo M; Fanti S; Zamagni E
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):712-719. PubMed ID: 29270787
[TBL] [Abstract][Full Text] [Related]
3. A Comparison of Different Staging Systems for Multiple Myeloma: Can the MRI Pattern Play a Prognostic Role?
Filonzi G; Mancuso K; Zamagni E; Nanni C; Spinnato P; Cavo M; Fanti S; Salizzoni E; Bazzocchi A
AJR Am J Roentgenol; 2017 Jul; 209(1):152-158. PubMed ID: 28418695
[TBL] [Abstract][Full Text] [Related]
4.
Jung SH; Kwon SY; Min JJ; Bom HS; Ahn SY; Jung SY; Lee SS; Park MR; Yang DH; Ahn JS; Kim HJ; Lee JJ
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):107-115. PubMed ID: 30187105
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of
Tu H; He Y; Huang T; Choe S; Lan X; Duan X; Sattar H; Li C; Zhou F
Eur J Haematol; 2018 Feb; 100(2):189-197. PubMed ID: 29226428
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment
Abe Y; Narita K; Kobayashi H; Kitadate A; Miura D; Takeuchi M; O'uchi E; O'uchi T; Matsue K
Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1325-1333. PubMed ID: 30687892
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of the international staging system of multiple myeloma and its comparison with the DS and IFM staging system in 122 Chinese patients].
Deng SH; Xu Y; Mai YJ; Wang YF; Zhao YZ; Zou DH; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):217-21. PubMed ID: 18843972
[TBL] [Abstract][Full Text] [Related]
8. Value of 18F-fluorodeoxyglucose uptake in positron emission tomography/computed tomography in predicting survival in multiple myeloma.
Haznedar R; Akı SZ; Akdemir OU; Ozkurt ZN; Ceneli O; Yağcı M; Sucak GT; Unlü M
Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1046-53. PubMed ID: 21287167
[TBL] [Abstract][Full Text] [Related]
9. Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe).
Nanni C; Zamagni E; Versari A; Chauvie S; Bianchi A; Rensi M; Bellò M; Rambaldi I; Gallamini A; Patriarca F; Gay F; Gamberi B; Cavo M; Fanti S
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):414-21. PubMed ID: 26475305
[TBL] [Abstract][Full Text] [Related]
10. Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma.
Cengiz A; Arda HÜ; Döğer F; Yavaşoğlu İ; Yürekli Y; Bolaman AZ
Turk J Haematol; 2018 Aug; 35(3):175-180. PubMed ID: 29806594
[TBL] [Abstract][Full Text] [Related]
11. Staging monoclonal plasma cell disease: comparison of the Durie-Salmon and the Durie-Salmon PLUS staging systems.
Fechtner K; Hillengass J; Delorme S; Heiss C; Neben K; Goldschmidt H; Kauczor HU; Weber MA
Radiology; 2010 Oct; 257(1):195-204. PubMed ID: 20851941
[TBL] [Abstract][Full Text] [Related]
12. [Screening of prognostic factors and comparing of staging systems of multiple myeloma].
Li J; Wu XB; Zhou Y; Wang X; Chen JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):926-9. PubMed ID: 22931656
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic value of the new international staging system in multiple myeloma. Comparison with Durie-Salmon staging system].
Conté L G; Figueroa M G; Lois V V; Cabrera C ME; León R A; García L H; Rojas R H
Rev Med Chil; 2008 Jan; 136(1):7-12. PubMed ID: 18483648
[TBL] [Abstract][Full Text] [Related]
14. [
Chen Z; Yang A; Chen A; Dong J; Lin J; Huang C; Zhang J; Liu H; Zeng Z; Miao W
Eur J Nucl Med Mol Imaging; 2024 Jan; ():. PubMed ID: 38286937
[TBL] [Abstract][Full Text] [Related]
15. Standardization of
Zamagni E; Nanni C; Dozza L; Carlier T; Bailly C; Tacchetti P; Versari A; Chauvie S; Gallamini A; Gamberi B; Caillot D; Patriarca F; Macro M; Boccadoro M; Garderet L; Barbato S; Fanti S; Perrot A; Gay F; Sonneveld P; Karlin L; Cavo M; Bodet-Milin C; Moreau P; Kraeber-Bodéré F
J Clin Oncol; 2021 Jan; 39(2):116-125. PubMed ID: 33151787
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study of multiple myeloma: a report of 182 cases].
Xu L; Wang Y; Wu W; Yan H; Gao XD; Yu Q; Shen ZX; Mi JQ
Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(14):972-7. PubMed ID: 20646647
[TBL] [Abstract][Full Text] [Related]
17. International prognostic index (IPI)--a critical comparison with five multiple myeloma staging systems in the group of 270 patients treated by conventional chemotherapy.
Scudla V; Zemanova M; Minarik J; Bacovsky J; Ordeltova M; Indrak K; Budikova M; Dusek L; Farbiakova V
Neoplasma; 2006; 53(4):277-84. PubMed ID: 16830053
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma.
Tandon N; Rajkumar SV; LaPlant B; Pettinger A; Lacy MQ; Dispenzieri A; Buadi FK; Gertz MA; Hayman SR; Leung N; Go RS; Dingli D; Kapoor P; Lin Y; Hwa YL; Fonder AL; Hobbs MA; Zeldenrust SR; Lust JA; Gonsalves WI; Russell SJ; Kumar SK
Blood Cancer J; 2017 Feb; 7(2):e528. PubMed ID: 28211889
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
[TBL] [Abstract][Full Text] [Related]
20. FDG-PET in the evaluation of myeloma in 2012.
Bodet-Milin C; Eugène T; Bailly C; Lacombe M; Frampas E; Dupas B; Moreau P; Kraeber-Bodéré F
Diagn Interv Imaging; 2013 Feb; 94(2):184-9. PubMed ID: 23287424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
